April W Armstrong

12PUBLICATIONS
20CO-AUTHORS
AllergyGene and molecular therapyToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 23, 2025
IL-17C as a Driver of Inflammation in Psoriasis.

George Han, April Armstrong, James G Krueger

|Sep 19, 2025
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.

Lawrence Green, April Armstrong, George Han

|Jul 29, 2025
Brodalumab: Seven-Year US Pharmacovigilance Report.

Mark G Lebwohl, John Y Koo, April W Armstrong

|Nov 26, 2024
Brodalumab: Six-Year US Pharmacovigilance Report.

Mark G Lebwohl, John Y Koo, April W Armstrong

|Sep 12, 2024
Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses.

Mark G Lebwohl, April W Armstrong, Andrew F Alexis

|May 09, 2024
Brodalumab: 5-Year US Pharmacovigilance Report.

Mark G Lebwohl, John Y Koo, April W Armstrong

Pageof 2